Bixlenvo为吉利德开辟HIV增长新路径。市场空间有多大？
· insidermonkey.com
吉利德科学公司
Gilead Sciences, Inc. (NASDAQ:GILD) has added another treatment to its HIV portfolio with the FDA approval of Bixlenvo, a once-daily pill for adults whose infec...
· insidermonkey.com
吉利德科学公司
Gilead Sciences, Inc. (NASDAQ:GILD) has added another treatment to its HIV portfolio with the FDA approval of Bixlenvo, a once-daily pill for adults whose infec...
More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI